Annual banned-substance review: analytical approaches in human sports drug testing / Mario Thevis, Tiia Kuuranne, Hans Geyer
- Drug Testing and Analysis 13 (2021) 17 November
- PMID: 34788500
- DOI: 10.1002/dta.3199
Contents:
- Introduction
- Anabolic Agent
- Anabolic-androgenic steroids
- Initial testing procedures: Comprehensive screening, metabolism studies
- Steroid profiling in urine and serum
- Confirmatory testing procedures – IRMS
- Other anabolic agents
- Peptide Hormones, Growth Factors, Related Substances, and Mimetics
- Erythropoietin-receptor agonists and hypoxia-inducible factor (HIF) activating agents
- Growth hormone, its fragments and releasing factors, chorionic gonadotrophin and luteinizing hormone (LH)
- β2‐Agonists
- Hormone and Metabolic Modulators
- Diuretics and other Masking Agents, Stimulants
- Glucocorticoids and cannabinoids
- Manipulation of blood and blood components
- Gene Doping
- Conclusion
Abstract
Most core areas of anti-doping research exploit and rely on analytical chemistry, applied to studies aiming at further improving the test methods' analytical sensitivity, the assays' comprehensiveness, the interpretation of metabolic profiles and patterns, but also at facilitating the differentiation of natural/endogenous substances from structurally identical but synthetically derived compounds and comprehending the athlete's exposome. Further, a continuously growing number of advantages of complementary matrices such as dried blood spots have been identified and transferred from research to sports drug testing routine applications, with an overall gain of valuable additions to the anti-doping field. In this edition of the annual banned-substance review, literature on recent developments in anti-doping published between October 2020 and September 2021 is summarized and discussed, particularly focusing on human doping controls and potential applications of new testing strategies to substances and methods of doping specified in the World Anti-Doping Agency's 2021 Prohibited List.
